Zhengye Biotechnology (NASDAQ:ZYBT) Stock Price Down 2.4% – What’s Next?

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) traded down 2.4% during trading on Monday . The stock traded as low as $0.82 and last traded at $0.8592. 5,888 shares traded hands during trading, a decline of 65% from the average session volume of 16,963 shares. The stock had previously closed at $0.88.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Zhengye Biotechnology in a research report on Friday, January 9th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Zhengye Biotechnology Trading Down 2.4%

The company has a 50 day moving average price of $1.16 and a 200 day moving average price of $3.40. The company has a quick ratio of 1.10, a current ratio of 1.49 and a debt-to-equity ratio of 0.01.

Institutional Investors Weigh In On Zhengye Biotechnology

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Jane Street Group LLC acquired a new stake in Zhengye Biotechnology in the 2nd quarter valued at approximately $1,158,000. Invesco Ltd. acquired a new stake in shares of Zhengye Biotechnology in the second quarter valued at $220,000. Geode Capital Management LLC purchased a new stake in shares of Zhengye Biotechnology in the 2nd quarter valued at $174,000. WINTON GROUP Ltd lifted its stake in Zhengye Biotechnology by 193.8% during the 4th quarter. WINTON GROUP Ltd now owns 63,297 shares of the company’s stock worth $73,000 after acquiring an additional 41,750 shares in the last quarter. Finally, XTX Topco Ltd lifted its stake in Zhengye Biotechnology by 71.4% during the 4th quarter. XTX Topco Ltd now owns 59,286 shares of the company’s stock worth $68,000 after acquiring an additional 24,697 shares in the last quarter.

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.